J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Bloomberg on MSN8mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
at GSK’s new headquarters in London’s Berkeley Square, at Elliott’s office a 15-minute walk away, or on Zoom. Elliott hasn’t ...